A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer
Clinical trial NCT00190710 · COMPLETED
Trial details
- NCT number
- NCT00190710
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.